SJS Investment Consulting’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.8K Sell
218
-2
-0.9% -$416 0.01% 447
2026
Q1
$46.5K Buy
220
+47
+27% +$10.1K 0.01% 420
2025
Q4
$35.6K Buy
173
+12
+7% +$2.26K ﹤0.01% 470
2025
Q3
$25.3K Buy
161
+150
+1,364% +$23.2K ﹤0.01% 484
2025
Q2
$1.85K Sell
11
-9
-45% -$1.34K ﹤0.01% 598
2025
Q1
$2.76K Hold
20
﹤0.01% 605
2024
Q4
$2.37K Sell
20
-18
-47% -$2.1K ﹤0.01% 635
2024
Q3
$4.2K Sell
38
-3
-7% -$314 ﹤0.01% 521
2024
Q2
$4.03K Sell
41
-1
-2% -$102 ﹤0.01% 489
2024
Q1
$4.7K Sell
42
-1
-2% -$108 ﹤0.01% 480
2023
Q4
$4.34K Sell
43
-279
-87% -$27.7K ﹤0.01% 415
2023
Q3
$28K Buy
322
+1
+0.3% +$90 0.01% 207
2023
Q2
$30.4K Sell
321
-7
-2% -$591 0.01% 187
2023
Q1
$24.8K Sell
328
-18
-5% -$1.36K 0.01% 207
2022
Q4
$26.6K Buy
346
+311
+889% +$23.6K 0.01% 205
2022
Q3
$2K Buy
+35
New +$2.22K ﹤0.01% 432
2022
Q1
$0 Buy
+7
New +$375 ﹤0.01% 769

Other funds holding CAH

SJS Investment Consulting's CAH Position: Q2 2026 in Review

SJS Investment Consulting reduced its Cardinal Health (CAH) stake by 0.91% in Q2 2026, selling an estimated $416 and leaving 218 shares worth $51.8K. The position accounts for 0.01% of the portfolio, ranked #447.

SJS Investment Consulting first reported a position in CAH in Q1 2022 and has held it in 17 quarters since. 857 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • SJS Investment Consulting held 218 shares of Cardinal Health worth $51.8K as of Q2 2026.
  • SJS Investment Consulting sold 2 Cardinal Health shares in Q2 2026, an estimated $416.
  • Cardinal Health made up 0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #447 holding.
  • SJS Investment Consulting first reported a position in Cardinal Health in Q1 2022 and has held it in 17 quarters since.
  • 857 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.